» Articles » PMID: 26905018

Erectile Function Recovery After Radical Prostatectomy in Men with High Risk Features

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2016 Feb 25
PMID 26905018
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We describe the efficacy of radical prostatectomy to achieve complete primary tumor excision while preserving erectile function in a cohort of patients with high risk features in whom surgical resection was tailored according to clinical staging, biopsy data, preoperative imaging and intraoperative findings.

Materials And Methods: In a retrospective review we identified 584 patients with high risk features (prostate specific antigen 20 ng/ml or greater, clinical stage T3 or greater, preoperative Gleason grade 8-10) who underwent radical prostatectomy between 2006 and 2012. The probability of neurovascular bundle preservation was estimated based on preoperative characteristics. Positive surgical margin rates and erectile function recovery were determined in patients who had some degree of neurovascular bundle preservation.

Results: The neurovascular bundles were resected bilaterally in 69 (12%) and unilaterally in 91 (16%) patients. The remaining patients had some degree of bilateral neurovascular bundle preservation. Preoperative features associated with a lower probability of neurovascular bundle preservation were primary biopsy Gleason grade 5 and clinical stage T3 disease. Among the patients with some degree of neurovascular bundle preservation 125 of 515 (24%) had a positive surgical margin, and 75 of 160 (47%) men with preoperatively functional erections and available erectile function followup had recovered erectile function within 2 years.

Conclusions: High risk features should not be considered an indication for complete bilateral neurovascular bundle resection. Some degree of neurovascular bundle preservation can be done safely by high volume surgeons in the majority of these patients with an acceptable rate of positive surgical margins. Nearly half of high risk patients with functional erections preoperatively recover erectile function after radical prostatectomy.

Citing Articles

Functional Impact of Neuro-Vascular Bundle Preservation in High Risk Prostate Cancer without Compromising Oncological Outcomes: A Propensity-Modelled Analysis.

Furrer M, Sathianathen N, Gahl B, Wuethrich P, Giannarini G, Corcoran N Cancers (Basel). 2023; 15(24).

PMID: 38136384 PMC: 10741934. DOI: 10.3390/cancers15245839.


Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer.

McCormick B, Chery L, Chapin B Transl Androl Urol. 2021; 10(5):2178-2187.

PMID: 34159100 PMC: 8185652. DOI: 10.21037/tau-20-1002.


Erectile function recovery at 12 months after radical prostatectomy for prostate cancer is not associated with overall survival.

Takeda T, Benfante N, Assel M, Mulhall J, Oya M, Touijer K Int J Urol. 2019; 26(9):934-935.

PMID: 31240770 PMC: 8415098. DOI: 10.1111/iju.14043.


Influence of multinerve-sparing, robot-assisted radical prostatectomy on the recovery of erection in Japanese patients.

Yumioka T, Honda M, Kimura Y, Yamaguchi N, Iwamoto H, Morizane S Reprod Med Biol. 2018; 17(1):36-43.

PMID: 29371819 PMC: 5768978. DOI: 10.1002/rmb2.12063.


Functional outcomes of clinically high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a multi-institutional analysis.

Abdollah F, Dalela D, Sood A, Sammon J, Cho R, Nocera L Prostate Cancer Prostatic Dis. 2017; 20(4):395-400.

PMID: 28462944 DOI: 10.1038/pcan.2017.26.


References
1.
Boorjian S, Eastham J, Graefen M, Guillonneau B, Karnes R, Moul J . A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol. 2011; 61(4):664-75. DOI: 10.1016/j.eururo.2011.11.053. View

2.
Zelefsky M, Eastham J, Cronin A, Fuks Z, Zhang Z, Yamada Y . Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol. 2010; 28(9):1508-13. PMC: 3731893. DOI: 10.1200/JCO.2009.22.2265. View

3.
Ward J, Slezak J, Blute M, Bergstralh E, Zincke H . Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005; 95(6):751-6. DOI: 10.1111/j.1464-410X.2005.05394.x. View

4.
Graefen M, Haese A, Pichlmeier U, Hammerer P, Noldus J, Butz K . A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol. 2001; 165(3):857-63. View

5.
Loeb S, Smith N, Roehl K, Catalona W . Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology. 2007; 69(6):1170-5. DOI: 10.1016/j.urology.2007.02.054. View